바이오 보존 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Biopreservation Market size is expected to reach USD 54.48 Billion in 2034 from USD 5.65 Billion (2025) growing at a CAGR of 28.64% during 2026-2034.

The Global Biopreservation Market is experiencing steady growth due to the rising demand for advanced storage solutions for biological materials. Increasing investments in regenerative medicine, stem cell research, and biobanking are key drivers supporting market expansion. The growing number of clinical trials and cell-based therapies is further accelerating the need for effective preservation media and equipment. Pharmaceutical and biotechnology companies are expanding research pipelines, which directly boosts demand. Technological advancements in cryopreservation and hypothermic storage are improving sample viability. The expansion of cord blood banking services is also contributing significantly. In the future, personalized medicine and cell therapy commercialization will further strengthen market prospects.

Another major growth factor in the biopreservation market is the increasing prevalence of chronic diseases and organ failures worldwide. Healthcare institutions are focusing on advanced tissue and organ preservation techniques to improve transplant success rates. Government initiatives supporting biomedical research infrastructure are creating favorable growth opportunities. The development of automated biostorage systems is enhancing operational efficiency in laboratories. Rising collaborations between research institutes and biotech firms are accelerating innovation. Emerging economies are investing in healthcare modernization and laboratory capabilities. Over the forecast period, digital monitoring and AI-enabled storage management are expected to enhance growth potential.

The market is also benefiting from the rapid growth of biobanks and gene therapy research across developed and developing regions. The increasing demand for long-term storage of vaccines and biologics has strengthened the adoption of preservation solutions. Cold chain logistics advancements are supporting safe transport and storage of sensitive biological samples. Companies are focusing on developing serum-free and chemically defined media to improve safety standards. Regulatory support for advanced therapeutic products is further encouraging adoption. Growing awareness regarding sample integrity and contamination control is influencing purchasing decisions. In the coming years, innovations in vitrification and cryogenic storage technologies will shape future market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Equipment
• Media
• Laboratory Information Management System (LIMS)

By Application

• Regenerative Medicine
• Bio-banking
• Drug Discovery

COMPANIES PROFILED

• Azenta US Inc, Biomatrica Inc, BioLife Solutions, MVE Biological Solutions, LabVantage Solutions Inc, TaylorWharton, Thermo Fisher Scientific Inc, Panasonic Corporation, XTherma Inc, PrincetonCryo, Stirling Ultracold
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOPRESERVATION MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Equipment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Media Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Laboratory Information Management System (LIMS) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOPRESERVATION MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Regenerative Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Bio-banking Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOPRESERVATION MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL BIOPRESERVATION INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Azenta US Inc
  • 8.2.2 Biomatrica Inc
  • 8.2.3 BioLife Solutions
  • 8.2.4 MVE Biological Solutions
  • 8.2.5 LabVantage Solutions Inc
  • 8.2.6 Taylor-Wharton
  • 8.2.7 Thermo Fisher Scientific Inc
  • 8.2.8 Panasonic Corporation
  • 8.2.9 X-Therma Inc
  • 8.2.10 PrincetonCryo
  • 8.2.11 Stirling Ultracold